Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
John Lauriello, MD
JCP
InfoPacks
How to Interpret Findings Concerning Newly Approved Antipsychotic Agents: Clinical Implications of the Lurasidone PEARL 2 Study
August 15, 2012
Christoph U. Correll
,
John Lauriello
,
Ashok Malla
, et al
JCP
Original Research
An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia
May 11, 2008
John Lauriello
,
Tim Lambert
,
Scott Andersen
, et al
JCP
Letter to the Editor
Reply to Letter to the Editor "Safety of Sildenafil for Antidepressant-Related Sexual Dysfunction"
November 30, 1999
H. George Nurnberg
,
Paula L. Hensley
,
John Lauriello
, et al
JCP
Original Research
Sildenafil for Iatrogenic Serotonergic Antidepressant Medication-Induced Sexual Dysfunction in 4 Patients
January 31, 1999
H. George Nurnberg
,
John Lauriello
,
Paula L. Hensley
, et al
«
1
2
